Recombinant human gamma-interferon in primary hepatocellular carcinoma

Forbes, Alastair ORCID:, Johnson, Philip J. and Williams, Roger (1985) Recombinant human gamma-interferon in primary hepatocellular carcinoma. Journal of the Royal Society of Medicine, 78 (10). pp. 826-829. ISSN 0141-0768

Full text not available from this repository. (Request a copy)


A phase II trial of recombinant human gamma-interferon in the treatment of unresectable primary hepatocellular carcinoma is reported. The trial was terminated prematurely after recruitment of only 7 patients because of unacceptable toxicity, predominantly renal. There was no evidence of response in any of the 7 patients but some evidence that disease progression was more rapid during the treatment period.

Item Type: Article
Uncontrolled Keywords: adult,carcinoma, hepatocellular,drug evaluation,female,humans,interferon-gamma,liver neoplasms,male,middle aged,time factors,alpha-fetoproteins,sdg 3 - good health and well-being ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Depositing User: Pure Connector
Date Deposited: 06 Aug 2014 10:44
Last Modified: 24 Oct 2022 23:58
DOI: 10.1177/014107688507801007

Actions (login required)

View Item View Item